Comparative Study of Intralesional Dexamethasone Plus Hyaluronidase & Oral Colchicine in Patients with Oral Submucous Fibrosis

Authors

  • Ganesh Prasad Neupane Department of Pharmacology Nepalgunj Medical College, Chisapani, Banke
  • Maya Rai Department of Pharmacology Nepalgunj Medical College, Chisapani, Banke
  • R. S. Rathore Department of Pharmacology Nepalgunj Medical College, Chisapani, Banke
  • V. K. Bhargava Department of Pharmacology Nepalgunj Medical College, Chisapani, Banke
  • A. K. Mahat Department of Pharmacology Nepalgunj Medical College, Chisapani, Banke
  • D. B. Dhami Department of Pharmacology Nepalgunj Medical College, Chisapani, Banke

DOI:

https://doi.org/10.3126/jngmc.v14i2.21542

Keywords:

Anti-fibrotic, Mouth opening, Oral submucous fibrosis (OSMF)

Abstract

Introduction: Oral Submucous Fibrosis (OSMF) is a precancerous condition of the oral mucosa. It is characterized by excessive production of collagen leading to inelasticity of the oral mucosa and atrophic changes of the epithelium.

Aim and objective: To evaluate the efficacy of oral Colchicine in comparison to intralesional injections of Dexamethasone plus Hyaluronidase in the management of OSMF patients.

Materials and Methods: Fourty patients with OSMF were randomly divided equally into two groups. 20 patients in Dexamethasone group received biweekly intralesional injections of Dexamethasone (4mg/ml) plus Hyaluronidase 1500 IU in buccal mucosa for a period of 12 weeks. Other 20 patients in Colchicine group received oral Colchicine 0.5 mg tablets twice daily for 12 weeks. Parameters taken in the study were burning sensation, and mouth opening. Descriptive statistics, paired t test and unpaired t test were used for statistical analysis.

Results and Conclusions: The pre- and post-treatment differences were found to be statistically significant for both the groups (p<0.001) and for both the treatment outcomes. When the average difference of the treatment outcomes was compared between the two study groups, statistically highly significant difference was noted (p <0.001) only in mouth opening but not in burning sensation.These encouraging results should prompt further clinical trials with Colchicine on a larger sample size to broaden the therapeutic usefulness of the drug in the management of OSMF.

 JNGMC,  Vol. 14 No. 2 December 2016, Page: 60-65

Downloads

Download data is not yet available.
Abstract
469
PDF
981

Downloads

Published

2018-10-31

How to Cite

Neupane, G. P., Rai, M., Rathore, R. S., Bhargava, V. K., Mahat, A. K., & Dhami, D. B. (2018). Comparative Study of Intralesional Dexamethasone Plus Hyaluronidase & Oral Colchicine in Patients with Oral Submucous Fibrosis. Journal of Nepalgunj Medical College, 14(2), 60–65. https://doi.org/10.3126/jngmc.v14i2.21542

Issue

Section

Original Articles